Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 781-790 of 2904 for cancer

Edit search filters
  1. Amino Acid Pet For Brain Tumors

    Rochester, MN

  2. Phase 1 Study To Investigate TCRTs KRAS Mutation In Unresectable, Advanced, And/or Metastatic Solid Tumors

    Jacksonville, FL

  3. S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery

    Rochester, MN

  4. Embolization Before Ablation Of Renal Cell Carcinoma (EMBARC)"

    Rochester, MN

  5. A Study Of A New Way To Treat Children And Young Adults With A Brain Tumor Called NGGCT

    Rochester, MN

  6. Early Identification Of Chemotherapy Induced Cardiac Toxicity

    Rochester, MN

  7. Ramucirumab And Paclitaxel Or FOLFIRI In Advanced Small Bowel Cancers

    Rochester, MN

  8. Testing The Effects Of Novel Therapeutics For Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  9. PEA For The Relief Of Chemotherapy-Induced Peripheral Neuropathy

    Eau Claire, WI, Rochester, MN

  10. A Study Of Ripretinib Vs Sunitinib In Patients With Advanced GIST With Specific KIT Exon Mutations Who Were Previously Treated With Imatinib

    Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer